Description

3-[2,4-Bis((3S)-3-Methylmorpholin-4-Yl)Pyrido[5,6-E]Pyrimidin-7-Yl]-n-Methylbenzamide CAS NO 1009298-59-2 is a high-purity, advanced pharmaceutical intermediate featuring a complex pyrido[5,6-e]pyrimidine core. This compound is specifically designed for use in the research and development of novel therapeutic agents, particularly in oncology and targeted disease pathways. It is an essential building block for medicinal chemists and pharmaceutical manufacturers engaged in the synthesis of sophisticated small-molecule drug candidates.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of investigational new drugs (INDs) and active pharmaceutical ingredients (APIs).
• Oncology Research: Serves as a core scaffold for developing kinase inhibitors and other targeted cancer therapies.
• Medicinal Chemistry R&D: Used in structure-activity relationship (SAR) studies and lead optimization for novel drug discovery programs.
• Biochemical Research: Employed as a reference standard or probe in enzymatic and cellular assays to study specific biological pathways.
• Preclinical Development: Supports the production of materials for toxicology, pharmacokinetics, and formulation studies.

Basic Information

Product Name	3-[2,4-Bis((3S)-3-Methylmorpholin-4-Yl)Pyrido[5,6-E]Pyrimidin-7-Yl]-n-Methylbenzamide
CAS No.	1009298-59-2
Molecular Formula	C29H35N7O3
Molecular Weight	529.64 g/mol
Synonyms	3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide; 1009298-59-2; N-Methyl-3-[2,4-bis[(3S)-3-methyl-4-morpholinyl]pyrido[5,6-e]pyrimidin-7-yl]benzamide; Benzamide, 3-[2,4-bis[(3S)-3-methyl-4-morpholinyl]pyrido[5,6-e]pyrimidin-7-yl]-N-methyl-; (S)-3-(2,4-bis(3-methylmorpholino)pyrido[5,6-e]pyrimidin-7-yl)-N-methylbenzamide
EINECS	Contact for details

Quality Control

Our 3-[2,4-Bis((3S)-3-Methylmorpholin-4-Yl)Pyrido[5,6-E]Pyrimidin-7-Yl]-n-Methylbenzamide is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and chiral purity, to ensure it meets the exacting standards required for pharmaceutical research. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting identity, assay, and impurity profiles.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccant or inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.